Ax

Updated FDA Calendar: Cypress Bioscience Looks Like a Buy

"Eli Lilly (LLY) filed a sBLA for Erbitux to be used in first-line, combination treatment for non-small cell lung cancer"

I think that even if the company Imclone is owned by Lilly, you should mention that the rights of the drug also belong to Bristol Myers (BMY)... This things should be mention in an article so investors are fully informed.